Ex vivo expansion of human hematopoietic stem cells by a small-molecule agonist of c-MPL.

[1]  T. Nakahata,et al.  AKR‐501 (YM477) a novel orally‐active thrombopoietin receptor agonist , 2009, European journal of haematology.

[2]  J. Bussel,et al.  Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial , 2009, The Lancet.

[3]  J. Luengo,et al.  Preclinical Activity of Eltrombopag (SB-497115), an Oral, Nonpeptide Thrombopoietin Receptor Agonist , 2009, Stem cells.

[4]  T. Suda,et al.  Reconstitution activity of hypoxic cultured human cord blood CD34-positive cells in NOG mice. , 2009, Biochemical and biophysical research communications.

[5]  Yoshikazu Tanaka,et al.  The effect of a novel, small non-peptidyl molecule butyzamide on human thrombopoietin receptor and megakaryopoiesis , 2008, Haematologica.

[6]  H. Kondoh.  Cellular life span and the Warburg effect. , 2008, Experimental cell research.

[7]  H. Lodish,et al.  Angiopoietin-like 5 and IGFBP2 stimulate ex vivo expansion of human cord blood hematopoietic stem cells as assayed by NOD/SCID transplantation. , 2008, Blood.

[8]  Göran Karlsson,et al.  Signaling pathways governing stem-cell fate. , 2008, Blood.

[9]  T. Suda,et al.  Thrombopoietin/MPL signaling regulates hematopoietic stem cell quiescence and interaction with the osteoblastic niche. , 2007, Cell stem cell.

[10]  Lina A. Thoren,et al.  Critical role of thrombopoietin in maintaining adult quiescent hematopoietic stem cells. , 2007, Cell stem cell.

[11]  D. Kuter.  New thrombopoietic growth factors. , 2007, Blood.

[12]  Brian Keith,et al.  Hypoxia-Inducible Factors, Stem Cells, and Cancer , 2007, Cell.

[13]  J. Nolta,et al.  Cytokine and integrin stimulation synergize to promote higher levels of GATA-2, c-myb, and CD34 protein in primary human hematopoietic progenitors from bone marrow. , 2007, Blood.

[14]  H. Nakauchi,et al.  Lnk negatively regulates self-renewal of hematopoietic stem cells by modifying thrombopoietin-mediated signal transduction , 2007, Proceedings of the National Academy of Sciences.

[15]  Jiwang Zhang,et al.  Ex vivo expansion of umbilical cord blood stem cells for transplantation: growing knowledge from the hematopoietic niche , 2007, Bone Marrow Transplantation.

[16]  S. Kōzuma,et al.  Highly Efficient Ex Vivo Expansion of Human Hematopoietic Stem Cells Using Delta1‐Fc Chimeric Protein , 2006, Stem cells.

[17]  K. Anderson,et al.  Cytokines regulate postnatal hematopoietic stem cell expansion: opposing roles of thrombopoietin and LNK. , 2006, Genes & development.

[18]  J. Whitesides,et al.  Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[19]  B. Brüne,et al.  Cytokines and hormones in the regulation of hypoxia inducible factor-1alpha (HIF-1alpha). , 2006, Cardiovascular & hematological agents in medicinal chemistry.

[20]  Mamoru Ito,et al.  A novel nonpeptidyl human c-Mpl activator stimulates human megakaryopoiesis and thrombopoiesis. , 2006, Blood.

[21]  N. Mahmud,et al.  Expansion of human umbilical cord blood SCID-repopulating cells using chromatin-modifying agents , 2006 .

[22]  K. Kaushansky,et al.  Thrombopoietin Stimulates Vascular Endothelial Cell Growth factor (VEGF) Production in Hematopoietic Stem Cells , 2005, Cell cycle.

[23]  S. Akira,et al.  Selective activation of STAT5 unveils its role in stem cell self-renewal in normal and leukemic hematopoiesis , 2005, The Journal of experimental medicine.

[24]  M. Weitzman,et al.  Gene therapy: twenty-first century medicine. , 2005, Annual review of biochemistry.

[25]  N. Fox,et al.  Thrombopoietin enhances expression of vascular endothelial growth factor (VEGF) in primitive hematopoietic cells through induction of HIF-1alpha. , 2004, Blood.

[26]  Robert S Negrin,et al.  Hematopoietic stem and progenitor cells: clinical and preclinical regeneration of the hematolymphoid system. , 2005, Annual review of medicine.

[27]  B. Sorrentino.  Clinical strategies for expansion of haematopoietic stem cells , 2004, Nature Reviews Immunology.

[28]  G. Sauvageau,et al.  In vitro and in vivo expansion of hematopoietic stem cells , 2004, Oncogene.

[29]  W. Ansorge,et al.  Molecular evidence for stem cell function of the slow-dividing fraction among human hematopoietic progenitor cells by genome-wide analysis. , 2004, Blood.

[30]  Irving L Weissman,et al.  Biology of hematopoietic stem cells and progenitors: implications for clinical application. , 2003, Annual review of immunology.

[31]  M. Simon,et al.  Expansion of human SCID-repopulating cells under hypoxic conditions. , 2003, The Journal of clinical investigation.

[32]  L. Huang,et al.  Hypoxia-inducible Factor and Its Biomedical Relevance* , 2003, Journal of Biological Chemistry.

[33]  K. Kaushansky.  Thrombopoietin: accumulating evidence for an important biological effect on the hematopoietic stem cell. , 2003, Annals of the New York Academy of Sciences.

[34]  N. Fox,et al.  Thrombopoietin expands hematopoietic stem cells after transplantation. , 2002, The Journal of clinical investigation.

[35]  N. Ferrara,et al.  VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism , 2002, Nature.

[36]  C. Begley,et al.  Development of pancytopenia with neutralizing antibodies to thrombopoietin after multicycle chemotherapy supported by megakaryocyte growth and development factor. , 2002, Blood.

[37]  C. Yang,et al.  Thrombocytopenia caused by the development of antibodies to thrombopoietin. , 2001, Blood.

[38]  T. A. Hewett,et al.  The relative quiescence of hematopoietic stem cells in nonhuman primates. , 2001, Blood.

[39]  Y. Miyakawa,et al.  Thrombopoietin Induces Phosphoinositol 3-Kinase Activation through SHP2, Gab, and Insulin Receptor Substrate Proteins in BAF3 Cells and Primary Murine Megakaryocytes* , 2001, The Journal of Biological Chemistry.

[40]  Mamoru Ito,et al.  Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor. , 2000, The Journal of clinical investigation.

[41]  K. Kaushansky,et al.  Thrombopoietin-induced activation of the mitogen-activated protein kinase (MAPK) pathway in normal megakaryocytes: role in endomitosis. , 1999, Blood.

[42]  J. Audet,et al.  Cell division tracking and expansion of hematopoietic long-term repopulating cells , 1999, Leukemia.

[43]  F.J. Sauvage,et al.  Role of c-mpl in early hematopoiesis. , 1998, Blood.

[44]  A. Roberts,et al.  Hematopoietic stem cell deficiencies in mice lacking c-Mpl, the receptor for thrombopoietin. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[45]  J. Dick,et al.  Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[46]  W. Piacibello,et al.  Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood. , 1997, Blood.

[47]  R. Salgia,et al.  Thrombopoietin induces activation of the phosphatidylinositol‐3′ kinase pathway and formation of a complex containing p85PI3K and the protooncoprotein p120CBL , 1997, Journal of cellular physiology.

[48]  H. Miyazaki,et al.  Thrombopoietin augments ex vivo expansion of human cord blood-derived hematopoietic progenitors in combination with stem cell factor and flt3 ligand , 1997, Leukemia.

[49]  David A. Williams,et al.  Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy , 1996, Nature Medicine.

[50]  W. Vainchenker,et al.  Phenotype and function of human hematopoietic cells engrafting immune-deficient CB17-severe combined immunodeficiency mice and nonobese diabetic-severe combined immunodeficiency mice after transplantation of human cord blood mononuclear cells. , 1996, Blood.

[51]  V. Broudy,et al.  The effect of thrombopoietin on the proliferation and differentiation of murine hematopoietic stem cells. , 1996, Blood.

[52]  N. Komatsu,et al.  Establishment and characterization of the thrombopoietin-dependent megakaryocytic cell line, UT-7/TPO. , 1996, Blood.

[53]  A. Assalian,et al.  MICROCAT: A Novel Cell Proliferation and Cytotoxicity Assay Based on WST-1 , 1996 .

[54]  Y. Yazaki,et al.  TPO/c-mpl ligand induces tyrosine phosphorylation of multiple cellular proteins including proto-oncogene products, Vav and c-Cbl, and Ras signaling molecules. , 1995, Biochemical and biophysical research communications.

[55]  M. Okuma,et al.  Thrombopoietin, c‐Mpl ligand, induces tyrosine phosphorylation of Tyk2, JAK2, and STAT3, and enhances agonists‐induced aggregation in platelets in vitro , 1995, FEBS letters.

[56]  R. Rees,et al.  Thrombopoietin (TPO) induces tyrosine phosphorylation and activation of STAT5 and STAT3 , 1995, FEBS letters.

[57]  J. Griffin,et al.  The c-Mpl Ligand (Thrombopoietin) Stimulates Tyrosine Phosphorylation of Jak2, Shc, and c-Mpl (*) , 1995, The Journal of Biological Chemistry.

[58]  M. C. Hu,et al.  Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor MpI , 1994, Cell.

[59]  William Vainchenker,et al.  c-Mpl ligand is a humoral regulator of megakaryocytopoiesis , 1994, Nature.

[60]  V. Broudy,et al.  Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin , 1994, Nature.

[61]  Scott R. Presnell,et al.  Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo , 1994, Nature.

[62]  D. Goeddel,et al.  Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand , 1994, Nature.

[63]  H. Lu,et al.  Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. , 1994, Cell.

[64]  H. Fujita,et al.  Establishment and characterization of an erythropoietin-dependent subline, UT-7/Epo, derived from human leukemia cell line, UT-7. , 1993, Blood.

[65]  M. Ogawa,et al.  Differentiation and proliferation of hematopoietic stem cells. , 1993, Blood.

[66]  G. Semenza,et al.  General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[67]  H. Nakauchi,et al.  Establishment and characterization of a human leukemic cell line with megakaryocytic features: dependency on granulocyte-macrophage colony-stimulating factor, interleukin 3, or erythropoietin for growth and survival. , 1991, Cancer research.

[68]  P. Quesenberry,et al.  Detection of a human CFC with a high proliferative potential. , 1989, Blood.

[69]  A. McMichael,et al.  Two monoclonal antiplatelet antibodies as markers of human megakaryocyte maturation: immunofluorescent staining and platelet peroxidase detection in megakaryocyte colonies and in in vivo cells from normal and leukemic patients. , 1982, Blood.